Insider Selling: Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Insider Sells $95,563.00 in Stock

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 7,351 shares of the company’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $13.00, for a total value of $95,563.00. Following the transaction, the insider now owns 232,681 shares in the company, valued at […]

Related Keywords

Massachusetts , United States , China , , Canaccord Genuity Group , Acadian Asset Management , Massachusetts Financial Services Co , Capital Partners , Nasdaq , China Universal Asset Management Co , Securities Exchange Commission , Y Mabs Therapeutics Inc , Y Mabs Therapeutics , Get Free Report , Thomas Gad , Exchange Commission , Abs Therapeutics , Genuity Group , Asset Management , Universal Asset Management , Massachusetts Financial Services , Financial Services , Y Mabs Therapeutics Daily ,